Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
Recruiting · NCT07640295 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations | Metastatic Pancreatic Ductal Adenocarcinoma | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT07640295 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jacobio Pharmaceuticals Co., Ltd. | 7 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Beijing Tsinghua Changgung Hospital | Beijing | China | 16 |
| Harbin Medical University Cancer Hospital | Harbin | China | 35 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Hubei Province Hospital | Wuhan | China | 1 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Jiangsu Province Hospital | Nanjing | China | 39 |
| Shanghai Jiaotong University School of Medicine Ruijin Hospital | Shanghai | China | 2 |
| Shanxi Cancer Hospital | Taiyuan | China | 17 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 61 |
| Wuhan Union Hospital Of China | Wuhan | China | 7 |
| Zhejiang Cancer Hospital | Hangzhou | China | 34 |
| Zhongnan Hospital of Wuhan University | Wuhan | China | 18 |